Clinical Trials Browser

Phase 2 × Recruiting × gemcitabine-oxaliplatin regimen × Clear all

NCT06320301 2024-03-20

Adebrelimab and a TKI in Combination With GEMOX in First-line Treatment of Advanced Biliary Tract Cancers (BTC)

Phase 2 Recruiting

Gastrointestinal

Biliary Tract Neoplasms